Ticagrelor + aspirin beneficial after elective CABG

April 25, 2018

(HealthDay)—For patients undergoing elective coronary artery bypass grafting (CABG), ticagrelor + aspirin is associated with significantly increased saphenous vein graft patency rates compared with aspirin alone, according to a study published in the April 24 issue of the Journal of the American Medical Association.

Qiang Zhao, M.D., Ph.D., from the Ruijin Hospital Shanghai Jiao Tong University School of Medicine, and colleagues randomized eligible patients aged 18 to 80 years with indications for elective CABG to start ticagrelor + aspirin (168 patients), ticagrelor alone (166 patients), or aspirin alone (166 patients) within 24 hours post-CABG; 92.2 percent of patients completed the trial.

The researchers found that the rates of saphenous vein graft patency were 88.7, 82.8, and 76.5 percent, respectively, with ticagrelor + aspirin, ticagrelor alone, and aspirin alone at one year post-CABG. There was a statistically significant difference between ticagrelor + aspirin versus aspirin alone (12.2 percent; 95 percent confidence interval, 5.2 to 19.2 percent; P < 0.001); for ticagrelor alone and aspirin alone, the difference was not statistically significant (6.3 percent; 95 percent confidence interval, −1.1 to 13.7 percent; P = 0.1). During one year of follow-up, there were five major bleeding episodes (three and two with ticagrelor + and ticagrelor alone, respectively).

"Further research with more is needed to assess comparative bleeding risks," the authors write.

Several authors disclosed financial ties to the medical device and pharmaceutical industries; the study was funded by AstraZeneca, the manufacturer of ticagrelor.

Explore further: Switching dual antiplatelet therapy beneficial after ACS

More information: Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Switching dual antiplatelet therapy beneficial after ACS

December 20, 2017
(HealthDay)—Switching dual antiplatelet therapy (DAPT) from aspirin plus ticagrelor or prasugrel to aspirin plus clopidogrel after acute coronary syndrome (ACS) provides benefits regardless of initial platelet reactivity, ...

AHA: Ticagrelor not shown to be superior to clopidogrel in PAD

November 16, 2016
(HealthDay)—Ticagrelor is not superior to clopidogrel for reduction of cardiovascular events in patients with peripheral artery disease, according to a study published online Nov. 13 in the New England Journal of Medicine ...

Dual antiplatelet Tx similar to aspirin post-CABG in diabetes

January 10, 2017
(HealthDay)—For post-coronary artery bypass grafting (CABG) patients with diabetes, cardiovascular and bleeding outcomes do not differ significantly with use of dual antiplatelet therapy (DAPT) versus aspirin, according ...

Chewing ticagrelor loading dose may be beneficial in STEMI

October 27, 2017
(HealthDay)—For patients with ST-segment elevation myocardial infarction (STEMI), chewing a loading dose (LD) of ticagrelor facilitates better early platelet inhibition, according to a study published online Oct. 25 in ...

Aspirin therapy appears safe before thyroid surgery

March 7, 2018
(HealthDay)—Continuing aspirin therapy before thyroid surgery does not appear to increase the risk of intraoperative bleeding, according to a study published online March 1 in JAMA Otolaryngology-Head & Neck Surgery.

PFA-100-measured aspirin resistance linked to CV events

October 31, 2017
(HealthDay)—Aspirin resistance, measured using the Platelet Function Analyzer (PFA)-100 system, is associated with cardiovascular events in aspirin-treated patients, according to a study published online Oct. 21 in the ...

Recommended for you

New model suggests cuffless, non-invasive blood pressure monitoring possible using pulse waves

October 16, 2018
A large team of researchers from several institutions in China and the U.S. has developed a model that suggests it should be possible to create a cuffless, non-invasive blood pressure monitor based on measuring pulse waves. ...

Why heart contractions are weaker in those with hypertrophic cardiomyopathy

October 16, 2018
When a young athlete suddenly dies of a heart attack, chances are high that they suffer from familial hypertrophic cardiomyopathy (HCM). Itis the most common genetic heart disease in the US and affects an estimated 1 in 500 ...

Novel genetic study sheds new light on risk of heart attack

October 12, 2018
Loss of a protein that regulates mitochondrial function can greatly increase the risk of myocardial infarction (heart attack), Vanderbilt scientists reported Oct. 3 in the journal eLife.

Researchers say ritual for orthodox Jewish men may offer heart benefits

October 11, 2018
A pilot study led by researchers at the University of Cincinnati (UC) College of Medicine suggests Jewish men who practice wearing tefillin, which involves the tight wrapping of an arm with leather banding as part of daily ...

Markers of dairy fat consumption linked to lower risk of type two diabetes

October 10, 2018
Higher levels of biomarkers of dairy fat consumption are associated with a lower risk of developing type 2 diabetes, according to new research published today in PLOS Medicine. The study, in more than 60,000 adults, was undertaken ...

Seed oils are best for LDL cholesterol

October 9, 2018
If you want to lower your low-density lipoprotein cholesterol, called LDL or, colloquially, "bad cholesterol," the research is clear about one thing: You should exchange saturated fats with unsaturated fat. If you want to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.